Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:45 PM
Ignite Modification Date:
2025-12-24 @ 7:45 PM
NCT ID:
NCT03787303
Eligibility Criteria:
Inclusion Criteria:
* Age greater than or equal to 18
* Male or female with diagnosis of metastatic breast carcinoma and documented history of hypothyroidism .
* TSH level within normal range at baseline
* Life expectancy estimated \> 3 months
* Ability and willingness to provide informed consent
Exclusion Criteria:
* Life expectancy estimated to be less than 3 months
* Is currently pregnant or intends to become pregnant during the duration of the study
* Active angina, New York Heart Association (NYHA) advanced \[Class III/IV\] congestive heart failure, or uncontrolled cardiac arrhythmia within 6 months of enrollment
* History of thyrotoxicosis
* History of adrenal insufficiency
* Hypersensitivity to any active or extraneous constituents in Triiodothyronine (T3)/liothyronine sodium
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
105 Years
Study:
NCT03787303
Study Brief:
Protocol Section:
NCT03787303